"Hualien Tzu Chi Hospital" was approved by the Taiwan FDA for allogenic dendritic cell therapy for "Stage IV solid cancer" and "Stage I to III solid cancers that have ineffective conventional treatment" on August 10, 2020.

"Hualien Tzu Chi Hospital" was approved by the Taiwan FDA for allogenic dendritic cell therapy for "Stage IV solid cancer" and "Stage I to III solid cancers that have ineffective conventional treatment" on August 10, 2020.

"Hualien Tzu Chi Hospital" is one of Ever Supreme’s collaborating hospitals.  On Aug 10, 2020, Tzu Chi Hospital was approved by the Taiwan FDA for "Stage 4 Solid Cancer" and " Stage I to III solid cancer after ineffective treatment” on allogenic dendritic cell (or referred to as DC) therapy, which provides treatment for qualified admitted patients who has indications diseases such as glioblastoma multiforme and metastatic brain cancer, epithelial ovarian cancer, pancreatic cancer, prostate cancer, head and neck cancer, liver cancer, breast cancer, and colorectal cancer.


 
BACK